Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As healthcare moves toward preventive, at-home ...
The characteristics of an ideal inhaler are based around the design and formulation of the device, patient use and the clinical effect, together with concordance and patient preference. To ensure ...
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...
New York, June 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, believe that a coronavirus ...
According to the report, the 'respiratory inhaler devices market' was valued at $32.4 billion in 2024, and is estimated to reach $51.9 billion by 2034, growing at a CAGR of 4.8% from 2025 to 2034.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results